CD147/EMMPRIN and CD44 are Potential Therapeutic Targets for Metastatic Prostate Cancer

Publisher： Bentham Science Publishers

E-ISSN： 1873-5576|10|3|287-306

ISSN： 1568-0096

Source： Current Cancer Drug Targets, Vol.10, Iss.3, 2010-05, pp. : 287-306

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

CD147/EMMPRIN: an effective therapeutic target for hepatocellular carcinoma

By Tang Xu   Guo Na   Xu Lixian   Gou Xingchun   Mi Man  

Journal of Drug Targeting, Vol. 21, Iss. 3, 2013-04 ,pp. : 224-231

Informa Healthcare

Access to resources Recommend Favorite

Therapeutic Targets for Metastatic Prostate Cancer

By  

Current Drug Targets, Vol. 4, Iss. 3, 2003-04 ,pp. : 251-261

Bentham Science Publishers

Access to resources Recommend Favorite

The Therapeutic Potential of 4-1BB (CD137) in Cancer

By  

Current Cancer Drug Targets, Vol. 5, Iss. 5, 2005-08 ,pp. : 357-363

Bentham Science Publishers

Access to resources Recommend Favorite

Androgen Receptor Cofactors in Prostate Cancer: Potential Therapeutic Targets of Castration-Resistant Prostate Cancer

By  

Current Cancer Drug Targets, Vol. 11, Iss. 7, 2011-09 ,pp. : 870-881

Bentham Science Publishers

Access to resources Recommend Favorite

HtrA Serine Proteases as Potential Therapeutic Targets in Cancer

By  

Current Cancer Drug Targets, Vol. 9, Iss. 4, 2009-06 ,pp. : 451-468

Bentham Science Publishers

Access to resources Recommend Favorite